Bristol Myers Expects Sales To Decline This Year; So Why Is The Stock Rising?

Core Insights - Bristol Myers Squibb (BMY) stock experienced a moderate rise following the announcement of adjusted earnings of $1.26 per share, surpassing analyst expectations of $1.23 per share [1] - The company reported fourth-quarter sales of $12.5 billion, exceeding the anticipated $12.28 billion [1] - In comparison to the previous year, Bristol Myers earned $1.67 per share on $12.34 billion in sales during the same period [1] Financial Performance - Adjusted earnings per share: $1.26, compared to analyst expectations of $1.23 [1] - Fourth-quarter sales: $12.5 billion, exceeding the forecast of $12.28 billion [1] - Year-over-year comparison: Previous year earnings were $1.67 per share on $12.34 billion in sales [1]